Very low-density lipoprotein activates nuclear factor-κB in endothelial cells

Circulation Research

Volumn 84, Issue 9, 1999, Pages 1085-1094

  Dichtl, Wolfgang ^a,b   Nilsson, Lennart ^b   Goncalves, Isabel ^a   Ares, Mikko P S ^a   Banfi, Cristina ^c   Calara, Federico ^a   Hamsten, Anders ^b   Eriksson, Per ^b   Nilsson, Jan ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Atherosclerosis; Fatty acid; Oxidation; Transcription factor; VLDL

Indexed keywords

ANTIOXIDANT; CYTOKINE; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; OLEIC ACID; PROBUCOL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CORONARY ARTERY DISEASE; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LIPID ANALYSIS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0033553429     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.9.1085     Document Type: Article

References (45)

1. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;1:2-14.
2. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990; 10:1067-1073.
3. Eriksson P, Nilsson L, Karpe F, Hamsten A. A very low density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1998;18:20-26.
4. Collins T. Biology of disease: endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499-508.
5. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
6. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nat Med. 1997;3:894-899.
7. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol. 1994;10:405-455.
8. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141-179.
9. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734-3737.
10. Alksnis M, Barkhem T, Strömstedt PE, Ahola H, Kutoh E, Gustafsson JÅ, Poellinger L, Nilsson S. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells: demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J Biol Chem. 1991;266:10078-10085.
11. Kalb VF Jr, Bernlohr RW. A new spectrophotometric assay for protein in cell extracts. Anal Biochem. 1997;82:362-371.
12. Eriksson P, Wrange Ö. Protein-protein contacts in the glucocorticoid receptor homodimer influence its DNA binding properties. J Biol Chem. 1990;265:3535-3542.
13. Redgrave TG, Carlsson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res. 1979;20:217-229.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
15. Spector AA, Hoak, JC. An improved method for the addition of long-chain free fatty acid to protein solutions. Anal Biochem. 1969;32-297-302.
16. Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res. 1996;37:907-925.
17. Calara F, Dimayuga P, Niemann A, Shah PK, Cercek B, Witztum J, Palinski W, Thyberg J, Nilsson J, Regnström J. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol. 1998;18:884-893.
18. Peng HB, Rajavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem. 1995;270:17050-17055.
19. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest. 1993;92:471-478.
20. Rajavashisth TB, Yamada H, Mishra NK. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL: involvement of nuclear factor-κB. Arterioscler Thromb Vasc Biol. 1995;15:1591-1598.
21. Ares MPS, Kallin B, Eriksson P, Nilsson J. Oxidized low-density lipoprotein induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:1584-1590.
22. Shackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO. Oxidized low density lipoprotein suppresses activation of NF-κB in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem. 1995;270:3475-3478.
23. Ohlsson BG, Englund MCO, Karlsson AK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-κB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest. 1996;98: 78-89.
24. 2+, NF-κB binding, and transcription of the TNF-α gene in murine macrophages. J Leukoc Biol. 1996;60:784-792.
25. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeuerle PA, Walli AK, Neumeier D. Dysregulation of monocytic nuclear factor-kappa B by oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol. 1997; 17:1901-1909.
26. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem. 1989;264:2599-2604.
27. Lougheed M, Zhang H, Steinbrecher UP. Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. J Biol Chem. 1993;266:14519-14525.
28. Schreck R, Alberman K, Baeuerle PA. Nuclear factor κB: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun. 1992;17:221-237.
29. Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA. 1997;15:3771-3776.
30. Karikó K, Rosenbaum H, Kua A, Zurier RB, Barnathan ES. Stimulatory effect of unsaturated fatty acids on the level of plasminogen activator inhibitor-1 mRNA in cultured human endothelial cells. FEBS Lett. 1995; 361:118-122.
31. Schmidt EB, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost. 1990;63:1-5.
32. Moller JM, Svaneborg N, Lervang HH, Varming K, Madsen P, Dyerberg J, Schmidt EB. The acute effect of a single very high dose of n-3 fatty acids on coagulation and fibrinolysis. Thromb Res. 1992;67:569-577.
33. Boberg M, Pollare T, Siegbahn A, Vessby B. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 1992;22:645-650.
34. Rao GN, Alexander RW, Runge MS. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinase activation, and growth in rat aortic smooth muscle cells. J Clin Invest. 1995;96:842-847.
35. Miller AM, Cullen MK, Kobb SM, Wenier RS. Effects of lipoxygenase and glutathione pathway inhibitors on leukemic cell line growth. J Lab Clin Med. 1989;113:355-361.
36. Ralph RK, Wojcik S. Inhibitors of lipoxygenase have antiproliferative effects on P815 murine mastocytoma cells. Cancer Lett. 1990;49: 181-185.
37. Ku G, Thomas CE, Akeson AL, Jackson RL. Induction of interleukin 1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J Biol Chem. 1992;267: 14183-14188.
38. Lutz O, Lave T, Frey A, Meraihi Z, Bach AC. Activities of lipoprotein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition. Metabolism. 1989;38:507-513.
39. Territo MC, Berliner JBA, Almada L, Ramirez R, Fogelman AM. β-Very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis. 1989;9:824-828.
40. Endemann G, Pronzcuk A, Friedman G, Lindsey S, Alderson L, Hayes KC. Monocyte adherence to endothelial cells in vitro is increased by β-VLDL. Am J Pathol. 1987;126:1-6.
41. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85: 1260-1266.
42. Schlichting E, Henriksen T, Lyberg T. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. Scand J Clin Lab Invest. 1994;54:465-473.
43. Kaneko T, Wada H, Wakita Y, Minamikawa K, Nakase T, Mori Y, Deguchi K, Shirakawa S. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins. Blood Coagul Fibrinolysis. 1994;5:385-392.
44. Jovinge S, Hamsten A, Tornvall P, Båvenholm P, Godsland I, Ericsson CG, de Faire U, Nilsson J. Evidence for a role of tumor necrosis factor-α in glucose and triglyceride abnormalities predisposing to coronary heart disease. Metabolism. 1998;47:113-118.
45. De Caterina R, Basta G, Lazzerini G, Dell'Omo G, Petrucci R, Morale M, Carmassi F, Pedrinelli R. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:2646-2654.